Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Management of ulcerative colitis].

Ch Rammert1, G A Kullak-Ublick

  • 1Abteilung Gastroenterologie und Hepatologie, Departement Innere Medizin, Universitätsspital, Zürich.

Therapeutische Umschau. Revue Therapeutique
|April 16, 2003
PubMed
Summary

Ulcerative colitis management involves 5-aminosalicylic acid (5-ASA) or steroids for mild to moderate cases. Severe or refractory disease may require immunosuppressants, cyclosporine, or surgery, with ongoing surveillance for colorectal cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.

Pharmacological research·2023
Same author

[A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].

Der Internist·2014
Same author

Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients.

Cardiology·2012
Same author

Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008.

Pharmacopsychiatry·2011
Same author

Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software.

Clinical pharmacology and therapeutics·2011
Same author

[Interactions with antiretroviral drugs].

Der Internist·2009

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Inflammatory Bowel Disease Research

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease requiring diagnosis via clinical, endoscopic, and histologic evaluation.
  • First-line treatment for UC typically involves 5-aminosalicylic acid (5-ASA) or topical steroids, with varying efficacy based on disease extent.
  • Management strategies must address induction of remission, maintenance therapy, and long-term complications.

Purpose of the Study:

  • To outline current therapeutic strategies for ulcerative colitis based on disease severity and extent.
  • To discuss the role of 5-ASA, steroids, immunosuppressants, and surgical options in UC management.
  • To highlight the importance of long-term complication management and cancer surveillance in UC patients.

Main Methods:

  • Review of established treatment guidelines and clinical practices for ulcerative colitis.
  • Categorization of therapeutic interventions based on disease presentation (distal, left-sided, extended, severe).
  • Consideration of maintenance therapy, management of frequent relapses, and treatment of fulminant disease courses.

Main Results:

  • Rectal 5-ASA or topical steroids are effective for distal/left-sided UC; oral 5-ASA for low-to-moderate extended disease; steroids for severe disease.
  • Immunosuppressants (azathioprine, 6-mercaptopurine) or intravenous cyclosporine are indicated for refractory or severe cases.
  • Proctocolectomy is an option for treatment failures, with new agents like infliximab under investigation.

Conclusions:

  • Effective ulcerative colitis management requires a stepwise approach tailored to disease severity and extent.
  • Long-term surveillance for complications like osteoporosis, anemia, and colorectal cancer is crucial.
  • Adherence to prophylactic 5-ASA treatment and regular endoscopic screening are vital for UC patient outcomes.

Related Experiment Videos